Cuprina Holdings is trading at $1.81, down 6.22% after its October 20 regular-session close at $1.93; no confirmed company-specific news directly explains the after-hours decline.
- An October 20 report covered approval of larger authorized share capital at the October 15 meeting, which could enable future equity issuance; no source linked it to the move.
- Major cryptocurrencies were slightly higher and U.S. indexes finished up; neither clearly matched the stock’s after-hours direction.
- The earlier clinic acquisition announcement is not a new October 20 catalyst.